VCYT Covered Call Strategy
VCYT (Veracyte, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis. It is also developing Percepta Genomic Atlas to help inform lung cancer treatment decisions; Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. Veracyte, Inc. has technology licensing and collaboration arrangements with Johnson & Johnson; Acerta Pharma; and CareDx. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
VCYT (Veracyte, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $3.05B, a trailing P/E of 34.57, a beta of 1.89 versus the broader market, a 52-week range of 22.61-50.71, average daily share volume of 943K, a public-listing history dating back to 2013, approximately 824 full-time employees. These structural characteristics shape how VCYT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.89 indicates VCYT has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a covered call on VCYT?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current VCYT snapshot
As of May 15, 2026, spot at $38.55, ATM IV 68.50%, IV rank 33.06%, expected move 19.64%. The covered call on VCYT below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this covered call structure on VCYT specifically: VCYT IV at 68.50% is mid-range versus its 1-year history, so the credit collected on a VCYT covered call sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 19.64% (roughly $7.57 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated VCYT expiries trade a higher absolute premium for lower per-day decay. Position sizing on VCYT should anchor to the underlying notional of $38.55 per share and to the trader's directional view on VCYT stock.
VCYT covered call setup
The VCYT covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With VCYT near $38.55, the first option leg uses a $40.48 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed VCYT chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 VCYT shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $38.55 | long |
| Sell 1 | Call | $40.48 | N/A |
VCYT covered call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
VCYT covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on VCYT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use covered call on VCYT
Covered calls on VCYT are an income strategy run on existing VCYT stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
VCYT thesis for this covered call
The market-implied 1-standard-deviation range for VCYT extends from approximately $30.98 on the downside to $46.12 on the upside. A VCYT covered call collects premium on an existing long VCYT position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether VCYT will breach that level within the expiration window. Current VCYT IV rank near 33.06% is mid-range against its 1-year distribution, so the IV signal is neutral; the covered call thesis on VCYT should anchor more to the directional view and the expected-move geometry. As a Healthcare name, VCYT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to VCYT-specific events.
VCYT covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. VCYT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move VCYT alongside the broader basket even when VCYT-specific fundamentals are unchanged. Short-premium structures like a covered call on VCYT carry tail risk when realized volatility exceeds the implied move; review historical VCYT earnings reactions and macro stress periods before sizing. Always rebuild the position from current VCYT chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on VCYT?
- A covered call on VCYT is the covered call strategy applied to VCYT (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With VCYT stock trading near $38.55, the strikes shown on this page are snapped to the nearest listed VCYT chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are VCYT covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the VCYT covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 68.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a VCYT covered call?
- The breakeven for the VCYT covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current VCYT market-implied 1-standard-deviation expected move is approximately 19.64%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on VCYT?
- Covered calls on VCYT are an income strategy run on existing VCYT stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current VCYT implied volatility affect this covered call?
- VCYT ATM IV is at 68.50% with IV rank near 33.06%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.